Extended recipients but not extended donors are associated with poor outcomes following lung transplantation

European Journal of Cardio-thoracic Surgery

Volumn 45, Issue 6, 2014, Pages 1040-1047

  Moreno, Paula ^a,b   Alvarez, Antonio ^a,b   Santos, Francisco ^a   Vaquero, José Manuel ^a   Baamonde, Carlos ^a,b   Redel, Javier ^a   Cerezo, Francisco ^a,b   Algar, Francisco Javier ^a,b   Salvatierra, Angel ^a,b  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b UNIVERSITY OF CÓRDOBA   (Spain)

Author keywords

Extended donors; Extended recipients; Lung donor criteria; Lung donor pool; Lung transplantation; Marginal donor lungs

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS;

ADULT; ARTICLE; BRONCHIOLITIS OBLITERANS; DONOR; EXTENDED DONOR; EXTENDED RECIPIENT; FEMALE; GRAFT RECIPIENT; HUMAN; LONG TERM SURVIVAL; LUNG FIBROSIS; LUNG INFILTRATE; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIMARY GRAFT DYSFUNCTION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SURGICAL MORTALITY; SURVIVAL; ADOLESCENT; KAPLAN MEIER METHOD; MIDDLE AGED; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; BRONCHIOLITIS OBLITERANS; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG TRANSPLANTATION; MIDDLE AGED; RETROSPECTIVE STUDIES; TISSUE DONORS; TRANSPLANT RECIPIENTS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84900563165     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1093/ejcts/ezt501     Document Type: Article

References (23)

1. Hardy JD, Webb WR, Dalton ML, Walker GR. Lung homo-transplantation in man. JAMA 1963;186:1065-74.
2. Punch JD, Hayes DH, LaPorte FB, McBride V, Seely MS. Organ donation and utilization in the United States, 1996-2005. Am J Transplant 2007;7: 1327-38.
3. Coll E, Santos F, Usetti P, Canela M, Borro JM, De la Torre M et al. The Spanish Lung Transplant Registry: first report of results (2006-2010). Arch Bronconeumol 2013;49:70-8.
4. Straznicka M, Follette DM, Eisner MD, Roberts PF, Menza RL, Babcock WD. Aggressive management of lung donors classified as unacceptable: excellent recipient survival one year after transplantation. J Thorac Cardiovasc Surg 2002;124:250-8.
5. Gabbay E, Williams TJ, Griffiths AP, Macfarlane LM, Kotsimbos TC, Esmore DS et al. Maximizing the utilization of donor organs offered for lung transplantation. Am J Respir Crit Care Med 1999;160:265-71.
6. Orens JB, Boehler A, de Perrot M, Estenne M, Glanville AR, Keshavjee S et al. A review of lung transplant donor acceptability criteria. J Heart Lung Transplant 2003;22:1183-200.
7. Orens JB, Estenne M, Arcasoy S, Conte JV, Corris P, Egan JJ et al. International Guidelines for the Selection of Lung Transplant Candidates: 2006 Update-A Consensus Report From the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2006;25:745-55.
8. Sundaresan S, Trachiotis GD, Aoe M, Patterson GA, Cooper JD. Donor lung procurement: assessment and operative technique. Ann Thorac Surg 1993;56:1409-13.
9. Alvarez A, Salvatierra A, Lama R, Algar J, Cerezo F, Santos F et al. Preservation with a retrograde second flushing of Eurocollins in clinical lung transplantation. Transplant Proc 1999;31:1088-90.
10. Christie JD, Carby M, Bag R, Corris P, Hertz M, Weill D. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction Part II: definition. A Consensus Statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2005;24:1454-9.
11. Estenne M, Maurer JR, Boehler A, Egan JJ, Frost A, Hertz M et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 2002;21:297-310.
12. Sundaresan S, Semenkovich J, Ochoa L, Richardson G, Trulock EP, Cooper JD et al. Successful outcome of lung transplantation is not compromised by the use ofmarginal donor lungs. J Thorac Cardiovasc Surg 1995;109:1075-80.
13. Bhorade SM, Vigneswaran W, McCabe MA, Garrity ER. Liberalization of donor criteria may expand the donor pool without adverse consequence in lung transplantation. J Heart Lung Transplant 2000;19:1200-4.
14. Novick RJ, Bennett LE, Meyer DM, Hosenpud JD. Influence of graft ischemic time and donor age on survival after lung transplantation. J Heart Lung Transplant 1999;18:425-31.
15. Moreno P, Alvarez A, Algar FJ, Cano JR, Espinosa D, Cerezo F et al. Experience of the Reina Sofia Hospital in lung transplantation from donors older than forty years. Transplant Proc 2008;40:3079-81.
16. Thabut G, Mal H, Cerrina J, Dartevelle P, Dromer C, Velly JF et al. Influence of donor characteristics on outcome after lung transplantation: a multicenter study. J Heart Lung Transplant 2005;24:1347-53.
17. Zafar F, Khan MS, Heinle JS, Adachi I, McKenzie ED, Schecter MG et al. Does donor arterial partial pressure of oxygen affect outcomes after lung transplantation?. A review of more than 12, 000 lung transplants. J Thorac Cardiothorac 2012;143:919-25.
18. Oto T, Griffiths AP, Levvey B, Pilcher DV, Whitford H, Kotsimbos TC et al. A donor history of smoking affects early but not late outcome in lung transplantation. Transplantation 2004;78:599-606.
19. Alvarez A, Moreno P, Espinosa D, Santos F, Illana J, Algar FJ et al. Assessment of lungs for transplantation: a stepwise analysis of 476 donors. Eur J Cardiothorac Surg 2010;37:432-9.
20. Singer JP, Blanc PD, Hoopes C, Golden JA, Koff JL, Leard LE et al. The impact of pretransplant mechanical ventilation on short-and long-term survival after lung transplantation. Am J Transplant 2011;11:2197-204.
21. Alvarez A, Algar FJ, Santos F, Lama R, Baamonde C, Cerezo F et al. Pediatric lung transplantation. Transplant Proc 2005;37:1519-22.
22. Pierre AF, Sekine Y, Hutcheon MA, Waddell TK, Keshavjee SH. Marginal donor lungs: a reassessment. J Thorac Cardiovasc Surg 2002;123:421-8.
23. Botha P, Trivedi D, Weir CJ, Searl CP, Corris PA, Dark JH et al. Extended donor criteria in lung transplantation: impact on organ allocation. J Thorac Cardiovasc Surg 2006;131:1154-60.